CJC-1295 No Dac 5mg Dosage Protocol
Contents
- Quickstart Highlights
- Dosing & Reconstitution Guide
- Standard Gradual Protocol (3.0 mL = ~1.67 mg/mL)
- Reconstitution Steps
- Supplies Needed
- Protocol Overview
- Dosing Protocol
- Storage Instructions
- Important Notes
- How This Works
- Potential Benefits & Side Effects
- Lifestyle Factors
- Injection Technique
- Recommended Source
- Important Note
- References
Quickstart Highlights
CJC-1295 NO DAC is a synthetic peptide made up of 29 amino acids, also known as Modified GRF (1–29). It functions as an analog of Growth Hormone-Releasing Hormone (GHRH), stimulating the pituitary gland to release growth hormone in a natural, pulsatile manner.
Unlike direct growth hormone use, this peptide supports the body’s natural hormonal feedback system, helping maintain balanced GH and IGF-1 levels. It is commonly associated with improvements in body composition, recovery, sleep quality, and overall metabolic function.
- Reconstitution: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
- Typical Daily Dose: 100–300 mcg (gradual increase recommended)
- Measurement Guide: 1 unit (0.01 mL) ≈ 16.7 mcg (U-100 syringe)
- Storage: Refrigerate after mixing; can be stored 1–2 weeks (longer if frozen properly)
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard Gradual Protocol (3.0 mL = ~1.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 150 mcg | 9 units (0.09 mL) |
| Weeks 5–6 | 200 mcg | 12 units (0.12 mL) |
| Weeks 7–12 | 250–300 mcg | 15–18 units (0.15–0.18 mL) |
Frequency: Once daily via subcutaneous injection, typically taken at bedtime to align with natural nighttime growth hormone release.
Reconstitution Steps
- Draw 3.0 mL of bacteriostatic water using a sterile syringe
- Slowly inject the water into the vial along the inner wall
- Gently swirl or roll the vial until fully dissolved (do not shake)
- Label the vial and store in the refrigerator (2–8°C), away from light
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Based on an 8–16 week protocol:
Peptide Vials (5 mg each)
- 8 weeks: ~2 vials
- 12 weeks: ~3 vials
- 16 weeks: ~4 vials
Insulin Syringes (U-100)
- 7 per week
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles)
- 8 weeks: ~6 mL (1 bottle)
- 12 weeks: ~9 mL (1 bottle)
- 16 weeks: ~12 mL (2 bottles)
Alcohol Swabs
- 2 per day
- 8 weeks: 112 swabs
- 12 weeks: 168 swabs
- 16 weeks: 224 swabs
Protocol Overview
- Goal: Support natural growth hormone release and improve recovery, body composition, and metabolic health
- Schedule: Daily injections for 8–12 weeks (extendable to 16 weeks)
- Dose Range: 100–300 mcg daily
- Reconstitution: 3.0 mL per vial
- Storage: Refrigerated after mixing; avoid repeated freeze–thaw
Dosing Protocol
- Start at 100–150 mcg daily
- Increase by ~50 mcg every 1–2 weeks as tolerated
- Target dose: 200–300 mcg daily
- Frequency: Once daily (subcutaneous)
- Timing: Best taken at bedtime
- Cycle Length: 8–12 weeks (optional extension to 16 weeks)
Storage Instructions
- Before mixing: Store refrigerated (2–8°C); for long-term storage, freezing is acceptable
- After mixing: Keep refrigerated and use within 1–2 weeks
- Avoid repeated freezing and thawing
- Allow vial to reach room temperature before opening to prevent moisture buildup
Important Notes
Key considerations for consistency and safe handling:
Use a new sterile syringe for each injection; dispose properly in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to minimize irritation.
Inject slowly and hold a few seconds before removing needle.
Document doses and site rotation.
Administer on an empty stomach (fasted ≥2 hours) for optimal GH response.
How This Works
CJC-1295 NO DAC mimics natural GHRH and binds to receptors in the pituitary gland, triggering the release of growth hormone in pulses.
Its modified structure improves stability while maintaining a short half-life, allowing it to produce GH spikes similar to the body’s natural rhythm. This helps avoid the risks associated with constant elevated GH levels while still promoting beneficial effects such as fat metabolism, recovery, and muscle support.
Potential Benefits & Side Effects
Potential Benefits
- Increased natural growth hormone and IGF-1 levels
- Improved body composition (lean mass gain and fat reduction)
- Better recovery and energy levels
- Enhanced sleep quality
Possible Side Effects
- Mild injection site irritation
- Temporary flushing
- Headaches (rare)
Lifestyle Factors
Supporting variables that may improve research consistency:
Follow a protein-rich, balanced diet.
Include resistance and aerobic training to support GH effects.
Prioritize sleep and manage stress.
Administer peptide fasted to maximize GH release.
Injection Technique
General guidance for subcutaneous administration:
- Clean the vial stopper and injection area with alcohol and allow to dry
- Gently pinch the skin and insert the needle at a 45–90° angle
- Inject slowly and steadily without aspirating
- Hold the needle in place for a few seconds before removing
- Rotate injection sites (abdomen, thighs, upper arms) to reduce irritation
Recommended Source
We recommend Fit Aminos for high-purity CJC-1295 research peptide products.
Why Fit Aminos?
- High-purity, lab-tested peptide batches with quality verification.
- Consistent handling and preparation processes designed to support reliable research protocols.
- Transparent sourcing and dependable fulfillment for research-grade compounds.
Important Note
This content is intended for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment. CJC-1295 remains an investigational peptide with limited human clinical data. For research use only. Not for human consumption.
References
Wikipedia — Modified GRF (1–29): structure, amino acid substitutions, and pharmacokinetics
Provides an overview of Modified GRF (1–29), including its structure, key amino acid modifications, and pharmacokinetic profile.
Journal of Clinical Endocrinology & Metabolism (2006) — Teichman et al.: Prolonged stimulation of GH and IGF‑I by CJC-1295 in healthy adults. This study demonstrates that CJC-1295 significantly increases growth hormone and IGF‑1 levels in healthy adults.
American Journal of Physiology (2006) — Alba et al.: Once‑daily CJC-1295 normalizes growth in GHRH knockout mice
Research shows that daily administration of CJC-1295 restores normal growth patterns in GHRH-deficient mice. Highlights its role in regulating growth hormone pathways.
Journal of Clinical Endocrinology & Metabolism (2006) — Veldhuis et al.: Pulsatile GH secretion persists during continuous CJC-1295 stimulation. Findings indicate that CJC-1295 maintains natural pulsatile GH secretion even with continuous stimulation.
PMC — Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum IGF‑1 Levels. This study explores how GH secretagogues increase IGF‑1 levels in hypogonadal men.